Health·Reuters - World (Google News)·8/26/2026, 3:09:45 PM·

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug - Reuters

The U.S. Food and Drug Administration has approved a new targeted therapy from Revolution Medicines for treating pancreatic cancer, marking a significant advancement in treatment options for this difficult-to-treat disease.

AI-generated summary. Social Pulse does not publish the full article. This brief is a neutral paraphrase by AI. Read the original at Reuters - World (Google News) using the link below.

Read Original Article

Related briefs

Google News - Business
FDA approves landmark pancreatic cancer drug that’s shown to improve survival - AP News
Google News - Business
F.D.A. Approves Drug Poised to Transform Care for Pancreatic Cancer - The New York Times
Google News - Health
Florida Moves to Let Children Attend School Without 4 Previously Required Vaccines - Currently.com
Google News - Health
What We Know About Australia’s Bird Flu, Which Has Crossed Over to Mammals - The New York Times
Google News - Business
FDA approves new blood test for Alzheimer’s disease - The Hill
Google News - Health
These Babies Grew Up With Strict Sugar Limits. Decades Later, The Results Are Dramatic. - ScienceAlert

COMMENTS · 0

Join the conversation

Be the first to comment.